Deborah Rhodes, 2011

“The data show what the data show.”

Rhodes criticized interpreting screening evidence through institutional hopes and described work on molecular breast imaging for women with dense tissue. She also discussed the difficulty of evaluating and adopting new tests. The primary record for Deborah Rhodes identifies Rhodes’s 2011 TED Blog interview on breast-cancer screening, dense tissue, evidence, and medical innovation. Reading Rhodes’s source beside Rhodes’s words separates Rhodes’s verified context from Rhodes’s later paraphrase. October 24 orders Rhodes’s series; October 24 does not tie Rhodes’s statement to Rhodes’s historical anniversary for Rhodes. The paired references let Rhodes’s readers compare Rhodes’s wording with Rhodes’s institutional record and Rhodes’s biography. That documented trail for Rhodes preserves Rhodes’s audience, Rhodes’s purpose, and Rhodes’s necessary limitation. Editors can quote Rhodes while keeping Rhodes’s original question visible to Rhodes’s readers.

The sentence is a discipline against motivated interpretation. Evidence can disappoint advocates, institutions, and inventors, but screening policy should follow validated benefits, harms, and uncertainty. A test that detects more lesions does not automatically reduce mortality and may increase false positives or overdiagnosis. Radiation, cost, access, downstream procedures, and comparative outcomes all matter. For Rhodes, the line becomes Rhodes’s interpretive lens rather than Rhodes’s complete clinical guidance. Applying Rhodes’s idea requires Rhodes’s current evidence, Rhodes’s affected communities, and Rhodes’s suitable outcomes. In health reporting, Rhodes should guide Rhodes’s inquiry before Rhodes supports Rhodes’s conclusion. A careful reading of Rhodes separates Rhodes’s descriptive findings from Rhodes’s moral judgment and Rhodes’s policy choice. Each layer around Rhodes needs Rhodes-specific support plus Rhodes-specific accountability. That structure keeps Rhodes’s memorable words connected to Rhodes’s documented scope and limits.

Women can discuss breast density and guideline-based options with clinicians while researchers continue direct comparisons. Regulators and health systems can require transparent endpoints and post-adoption monitoring. Rhodes’s phrase is spare but demanding. It asks health innovation to earn trust through evidence rather than expectation. The continuing question from Rhodes is practical for Rhodes: which decision embodies Rhodes’s principle? Readers can test Rhodes’s relevance when Rhodes’s practical questions for Rhodes ask who gains, where Rhodes’s risk falls, and how Rhodes’s improvement gets measured. Organizations honor Rhodes by assigning Rhodes-specific responsibility, Rhodes-specific resources, Rhodes-specific timelines, and Rhodes-specific public feedback. Individuals may use Rhodes for Rhodes-specific reflection while qualified care addresses Rhodes’s personal relevance. That distinction lets Rhodes inspire Rhodes-specific action without turning Rhodes’s editorial context into Rhodes’s medical advice. A transparent Rhodes review lets Rhodes’s principle face Rhodes’s real outcomes and necessary correction.